Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate

Anesthesiology

Volumn 120, Issue 4, 2014, Pages 935-942

  Derive, Marc ^a   Boufenzer, Amir ^a   Gibot, Sébastien ^a,b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; OLIGOPEPTIDE; PEPTIDE LR12; PLACEBO; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; LAURIC ACID DERIVATIVE; LISSAMINE RHODAMINE DODECANOIC ACID; LISSAMINE-RHODAMINE DODECANOIC ACID; RHODAMINE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; BODY TEMPERATURE; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; DRUG HALF LIFE; HEART RATE; INFLAMMATION; LEUKOCYTE COUNT; LEUKOPENIA; MACACA FASCICULARIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAL SIGN; ANIMAL; BLOOD; BLOOD PRESSURE; BONE MARROW CELL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; RANDOMIZATION; SEPTIC SHOCK;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTOXINS; INJECTIONS, INTRAVENOUS; LAURIC ACIDS; LEUKOPENIA; MACACA FASCICULARIS; MALE; MYELOID CELLS; RANDOM ALLOCATION; RHODAMINES; SHOCK, SEPTIC;

EID: 84901701462     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000078     Document Type: Article

References (30)

1. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, López MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, Schoenfeld DA, Storey JD, Cobb JP, Warren HS, Moldawer LL, Herndon DN, Lowry SF, Maier RV, Davis RW, Tompkins RG; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 2011; 208:2581-90.
2. Ford JW, McVicar DW: TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009; 21:38-46.
3. Pierobon D, Bosco MC, Blengio F, Raggi F, Eva A, Filippi M, Musso T, Novelli F, Cappello P, Varesio L, Giovarelli M: Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. Eur J Immunol 2013; 43:949-66.
4. Arts RJ, Joosten LA, van-der-Meer JW, Netea MG: TREM-1: Intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol 2013; 93:209-15.
5. Hara H, Ishihara C, Takeuchi A, Imanishi T, Xue L, Morris SW, Inui M, Takai T, Shibuya A, Saijo S, Iwakura Y, Ohno N, Koseki H, Yoshida H, Penninger JM, Saito T: The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 2007; 8:619-29.
6. Fortin CF, Lesur O, Fulop T Jr: Effects of TREM-1 activation in human neutrophils: Activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol 2007; 19:41-50.
7. Ornatowska M, Azim AC, Wang X, Christman JW, Xiao L, Joo M, Sadikot RT: Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1377-84.
8. Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC: A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200:1419-26.
9. Gibot S, Buonsanti C, Massin F, Romano M, Kolopp-Sarda MN, Benigni F, Faure GC, Béné MC, Panina-Bordignon P, Passini N, Lévy B: Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74:2823-30.
10. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410:1103-7.
11. Gibot S, Massin F, Alauzet C, Montemont C, Lozniewski A, Bollaert PE, Levy B: Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 2008; 36:504-10.
12. Kamei K, Yasuda T, Ueda T, Qiang F, Takeyama Y, Shiozaki H: Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17:305-12.
13. Gibot S, Massin F, Alauzet C, Derive M, Montemont C, Collin S, Fremont S, Levy B: Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats. Shock 2009; 32:633-7.
14. Schenk M, Bouchon A, Seibold F, Mueller C: TREM-1- expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007; 117:3097-106.
15. Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H: Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum 2009; 60:1615-23.
16. Kuai J, Gregory B, Hill A, Pittman DD, Feldman JL, Brown T, Carito B, O'Toole M, Ramsey R, Adolfsson O, Shields KM, Dower K, Hall JP, Kurdi Y, Beech JT, Nanchahal J, Feldmann M, Foxwell BM, Brennan FM, Winkler DG, Lin LL: TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford) 2009; 48:1352-8.
17. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, Stohl W: Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2009; 68:1768-74.
18. Washington AV, Schubert RL, Quigley L, Disipio T, Feltz R, Cho EH, McVicar DW: A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets. Blood 2004; 104:1042-7.
19. Barrow AD, Astoul E, Floto A, Brooke G, Relou IA, Jennings NS, Smith KG, Ouwehand W, Farndale RW, Alexander DR, Trowsdale J: Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2. J Immunol 2004; 172:5838-42.
20. Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, De La Mota A, Schubert RL, Gomez-Rodriguez J, Cheng J, Dutra A, Pak E, Chertov O, Rivera L, Morales J, Lubkowski J, Hunter R, Schwartzberg PL, McVicar DW: TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest 2009; 119:1489-501.
21. Gattis JL, Washington AV, Chisholm MM, Quigley L, Szyk A, McVicar DW, Lubkowski J: The structure of the extracellular domain of triggering receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment. J Biol Chem 2006; 281:13396-403.
22. Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S: Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol 2012; 188:5585-92.
23. Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, Lozniewski A, Leroy P, Tran N, Gibot S: Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock 2013; 39:176-82.
24. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110:3507-12.
25. Kolota G: Mice Falls Short as Test Subjects for Humans' Deadly Ills. The New York Times, February 12, 2013, A19.
26. Derive M, Massin F, Gibot S: Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself 2010; 1:225-30.
27. Haselmayer P, Grosse-Hovest L, von-Landenberg P, Schild H, Radsak MP: TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110:1029-35.
28. Klesney-Tait J, Keck K, Li X, Gilfillan S, Otero K, Baruah S, Meyerholz DK, Varga SM, Knudson CJ, Moninger TO, Moreland J, Zabner J, Colonna M: Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest 2013; 123:138-49.
29. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL; ACCESS Study Group: Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial. JAMA 2013; 309:1154-62.
30. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD; Prowess-Shock Study Group: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366:2055-64.